Mission Bio Raises $30M in Series B Financing

Dec 13, 2018

NEW YORK (GenomeWeb) – Mission Bio said today that it has raised $30 million in a Series B financing round led by Agilent Technologies, Cota Capital, LAM Capital, and Mayfield, bringing its total financing to more than $50 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

In Brief This Week: Novogene, Hologic, Agilent, Diagenode
Spontaneous Preterm Birth Clues Identified in Cervicovaginal Microbiome
Germany Plans Limited Coverage of NIPT for High-Risk Pregnancies
Bruker TB Test, PCR Platform Receives CE-IVD Mark
Single-Cell Sperm Sequencing Reveals New Details About Recombination
New Products Posted to GenomeWeb: Roche Diagnostics, Asuragen, Mission Bio

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.

Menu